To overcome these limitations, researchers have made triple transgenic mice (3XTg-AD) harboring a tau transgene (tauP301L) in addition to APPSWE and presenilin-1 (PS1M146V) mutations (31), or developed promoters exclusively expressing transgenes in neurons. The gene discussed is MAPT; the disease is Alzheimer disease.